5 Star Review

"Most helpful, steered us in the right direction for treatmen...." see more

Elaine C. - Mesothelioma Patient

5 Star Review

"Because of their guidance, I was able to navigate getting my...." see more

Deanna B. - Daughter of a Mesothelioma Patient

5 Star Review

"Hearing the news about my mother's diagnosis was heartbreaki...." see more

Danielle W. - Daughter of a Mesothelioma Patient

5 Star Review

"My son Carlos was diagnosed with this terrible and unknown d...." see more

Martha M. - Mother of a Mesothelioma Patient

5 Star Review

"Extremely communicative and helped my dad get an appointment...." see more

Sunni H. - Loved One of a Mesothelioma Patient

5 Star Review

"Danielle DiPietro was an invaluable resource for me. Her sug...." see more

Deborah C. - Spouse of a Mesothelioma Patient

5 Star Review

"I was very grateful and appreciative of Dr. Smart from The M...." see more

Kimberlin C. - Spouse of a Mesothelioma Patient

5 Star Review

"In January of 2016, my husband was diagnosed with peritoneal...." see more

Gloria R. - Spouse of a Mesothelioma Patient

Expertise:
Immunotherapy
Hematology
Speciality:
Medical Oncology
Gender:
Female
Language:
English

Get to Know Dr. Rama Balaraman

Medical oncologist Dr. Rama Balaraman believes that novel immunotherapy has changed the way malignant pleural mesothelioma should be treated. She has patients to prove it.

Balaraman has been in practice for almost two decades, long enough to remember when mesothelioma treatment was mostly palliative in nature, a philosophy that has become a thing of the past.

“For the first time, we’re seeing dramatic improvements,” she said. “Hopefully, at some point, we’ll find a cure. We certainly are moving in that direction now.”

At Florida Cancer Affiliates in Ocala, Balaraman treats a variety of lung diseases, along with head and neck cancers.  The practice is part of the U.S. Oncology Network, which includes more than 1,000 physicians. Its goal is expanding access to integrated cancer care throughout the country.

Balaraman has patients doing well with pembrolizumab and nivolumab, known by the brand names Keytruda and Opdivo, respectively. These are two highly touted immunotherapy drugs that many researchers believe are changing the face of rare cancers such as mesothelioma.

Specialties of Dr. Rama Balarama

  • Immunotherapy
  • Hematology
  • Lung cancer
  • Pleural mesothelioma
  • Head and neck cancer
  • Breast cancer

Dr. Rama Balarama’s Experience and Medical Education

  • Florida Cancer Affiliates
  • Thanjavur Medical College, India (M.D.)
  • St. Mary’s Health Center, Saint Louis University School of Medicine (Residency)
  • Launceston General Hospital, Australia (Fellowship)
  • University of Missouri (Fellowship)

Awards and Certifications

  • American Board of Certified Hematology
  • American Board of Certified Medical Oncology
  • Royal Australasian College of Physicians (Fellow)
  • American Society of Clinical Oncology (Member)
  • American Society of Hematology (Member)

Publications of Dr. Rama Balarama

  • Monsour, E.P., Pothen, J. & Balaraman, R. (2019, October 2). A Novel Approach to the Treatment of Pembrolizumab-induced Psoriasis Exacerbation: A Case Report. Cureus.
  • Upaganlawar, A. & Balaraman, R. (2012, January). Effects of Lagenaria Sicessaria Fruit Juice on Lipid Profile and Glycoprotein Contents in Cardiotoxicity Induced by Isoproterenol in Rats. Toxicology International.
  • Khandelwal, V. et al. (2010, September 7). Hemidesmus indicus and Hibiscus rosa-sinensis Affect Ischemia Reperfusion Injury in Isolated Rat Hearts. Evidence Based Complementary Alternative Medicine.